砷化合物的摄入调控机制

雷梦瑾; 龙艳敏; 胡立刚; 阴永光; 刘广良; 蔡勇

doi:10.7524/j.issn.0254-6108.2021102205

[1]

DUKER A A, CARRANZA E J M, HALE M. Arsenic geochemistry and health [J]. Environment International, 2005, 31(5): 631-641. doi: 10.1016/j.envint.2004.10.020

[2]

MANDAL B K, SUZUKI K T. Arsenic round the world: A review [J]. Talanta, 2002, 58(1): 201-235. doi: 10.1016/S0039-9140(02)00268-0

[3]

LI Y B, DUAN Z W, LIU G L, et al. Evaluation of the possible sources and controlling factors of toxic metals/metalloids in the Florida Everglades and their potential risk of exposure [J]. Environmental Science & Technology, 2015, 49(16): 9714-9723.

[4]

NAUJOKAS M F, ANDERSON B, AHSAN H, et al. The broad scope of health effects from chronic arsenic exposure: Update on a worldwide public health problem [J]. Environmental Health Perspectives, 2013, 121(3): 295-302. doi: 10.1289/ehp.1205875

[5]

RODRÍGUEZ-LADO L, SUN G F, BERG M, et al. Groundwater arsenic contamination throughout China [J]. Science, 2013, 341(6148): 866-868. doi: 10.1126/science.1237484

[6]

HUNT K M, SRIVASTAVA R K, ELMETS C A, et al. The mechanistic basis of arsenicosis: Pathogenesis of skin cancer [J]. Cancer Letters, 2014, 354(2): 211-219. doi: 10.1016/j.canlet.2014.08.016

[7]

STRAIF K, BENBRAHIM-TALLAA L, BAAN R, et al. A review of human carcinogens—Part C: Metals, arsenic, dusts, and fibres [J]. The Lancet Oncology, 2009, 10(5): 453-454. doi: 10.1016/S1470-2045(09)70134-2

[8]

CHEN Y, WU F, GRAZIANO J H, et al. Arsenic exposure from drinking water, arsenic methylation capacity, and carotid intima-media thickness in Bangladesh [J]. American Journal of Epidemiology, 2013, 178(3): 372-381. doi: 10.1093/aje/kwt001

[9]

MAULL E A, AHSAN H, EDWARDS J, et al. Evaluation of the association between arsenic and diabetes: A National Toxicology Program workshop review [J]. Environmental Health Perspectives, 2012, 120(12): 1658-1670. doi: 10.1289/ehp.1104579

[10]

NARANMANDURA H, IBATA K, SUZUKI K T. Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells [J]. Chemical Research in Toxicology, 2007, 20(8): 1120-1125. doi: 10.1021/tx700103y

[11]

NARANMANDURA H, CAREW M W, XU S, et al. Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells [J]. Chemical Research in Toxicology, 2011, 24(9): 1586-1596. doi: 10.1021/tx200291p

[12]

LIU F, JAN K Y. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells [J]. Free Radical Biology and Medicine, 2000, 28(1): 55-63. doi: 10.1016/S0891-5849(99)00196-3

[13]

LI Y X, HE M, CHEN B B, et al. Inhibition of arsenite methylation induces synergistic genotoxicity of arsenite and benzo(a)Pyrene diol epoxide in SCC-7 cells [J]. Metallomics, 2018, 11(1): 176-182.

[14]

ZHOU X X, SUN X, MOBARAK C, et al. Differential binding of monomethylarsonous acid compared to arsenite and arsenic trioxide with zinc finger peptides and proteins [J]. Chemical Research in Toxicology, 2014, 27(4): 690-698. doi: 10.1021/tx500022j

[15]

ZHAO L H, CHEN S M, JIA L Y, et al. Selectivity of arsenite interaction with zinc finger proteins [J]. Metallomics, 2012, 4(9): 988-994. doi: 10.1039/c2mt20090b

[16]

RATNAIKE R N. Acute and chronic arsenic toxicity [J]. Postgraduate Medical Journal, 2003, 79(933): 391-396. doi: 10.1136/pmj.79.933.391

[17]

SHEN S W, LI X F, CULLEN W R, et al. Arsenic binding to proteins [J]. Chemical Reviews, 2013, 113(10): 7769-7792. doi: 10.1021/cr300015c

[18]

SUZUKI K T, IWATA K, NARANMANDURA H, et al. Metabolic differences between two dimethylthioarsenicals in rats [J]. Toxicology and Applied Pharmacology, 2007, 218(2): 166-173. doi: 10.1016/j.taap.2006.10.027

[19]

NARANMANDURA H, IWATA K, SUZUKI K T, et al. Distribution and metabolism of four different dimethylated arsenicals in hamsters [J]. Toxicology and Applied Pharmacology, 2010, 245(1): 67-75. doi: 10.1016/j.taap.2010.02.001

[20]

GARBINSKI L D, ROSEN B P, CHEN J. Pathways of arsenic uptake and efflux [J]. Environment International, 2019, 126: 585-597. doi: 10.1016/j.envint.2019.02.058

[21]

ROGGENBECK B A, BANERJEE M, LESLIE E M. Cellular arsenic transport pathways in mammals [J]. Journal of Environmental Sciences, 2016, 49: 38-58. doi: 10.1016/j.jes.2016.10.001

[22]

CHÁVEZ-CAPILLA T, MAHER W, KELLY T, et al. Evaluation of the ability of arsenic species to traverse cell membranes by simple diffusion using octanol-water and liposome-water partition coefficients [J]. Journal of Environmental Sciences, 2016, 49: 222-232. doi: 10.1016/j.jes.2016.08.007

[23]

RICARDOVILLA-BELLOSTA, GIRAL H, FERRER-DUFOL A, et al. Role of phosphate transporters in the membrane transport of arsenate [J]. Toxicology Letters, 2006, 164: S150.

[24]

VILLA-BELLOSTA R, SORRIBAS V. Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate [J]. Toxicology and Applied Pharmacology, 2008, 232(1): 125-134. doi: 10.1016/j.taap.2008.05.026

[25]

VILLA-BELLOSTA R, SORRIBAS V. Arsenate transport by sodium/phosphate cotransporter type IIb [J]. Toxicology and Applied Pharmacology, 2010, 247(1): 36-40. doi: 10.1016/j.taap.2010.05.012

[26]

CALATAYUD M, BARRIOS J A, VÉLEZ D, et al. In vitro study of transporters involved in intestinal absorption of inorganic arsenic [J]. Chemical Research in Toxicology, 2012, 25(2): 446-453. doi: 10.1021/tx200491f

[27]

LAFORENZA U, BOTTINO C, GASTALDI G. Mammalian aquaglyceroporin function in metabolism [J]. Biochimica et Biophysica Acta (BBA) - Biomembranes, 2016, 1858(1): 1-11. doi: 10.1016/j.bbamem.2015.10.004

[28]

ROJEK A, PRAETORIUS J, FRØKIAER J, et al. A current view of the mammalian aquaglyceroporins [J]. Annual Review of Physiology, 2008, 70: 301-327. doi: 10.1146/annurev.physiol.70.113006.100452

[29]

RAMÍREZ-SOLÍS A, MUKOPADHYAY R, ROSEN B P, et al. Experimental and theoretical characterization of arsenite in water: Insights into the coordination environment of As-O [J]. Inorganic Chemistry, 2004, 43(9): 2954-2959. doi: 10.1021/ic0351592

[30]

LIU Z J. Roles of vertebrate aquaglyceroporins in arsenic transport and detoxification [J]. Advances in Experimental Medicine and Biology, 2010, 679: 71-81.

[31]

LEUNG J, PANG A N, YUEN W H, et al. Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells [J]. Blood, 2007, 109(2): 740-746. doi: 10.1182/blood-2006-04-019588

[32]

NARANMANDURA H, OGRA Y, IWATA K, et al. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells [J]. Toxicology and Applied Pharmacology, 2009, 238(2): 133-140. doi: 10.1016/j.taap.2009.05.006

[33]

LEE T C, HO I C, LU W J, et al. Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line [J]. Journal of Biological Chemistry, 2006, 281(27): 18401-18407. doi: 10.1074/jbc.M601266200

[34]

HAGENBUCH B, STIEGER B. The SLCO (former SLC21) superfamily of transporters [J]. Molecular Aspects of Medicine, 2013, 34(2/3): 396-412.

[35]

ROTH M, OBAIDAT A, HAGENBUCH B. OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies [J]. British Journal of Pharmacology, 2012, 165(5): 1260-1287. doi: 10.1111/j.1476-5381.2011.01724.x

[36]

LU W J, TAMAI I, NEZU J I, et al. Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells [J]. Journal of Biomedical Science, 2006, 13(4): 525-533. doi: 10.1007/s11373-006-9071-0

[37]

MUECKLER M, THORENS B. The SLC2 (GLUT) family of membrane transporters [J]. Molecular Aspects of Medicine, 2013, 34(2/3): 121-138.

[38]

LIU Z J, STYBLO M, ROSEN B P. Methylarsonous acid transport by aquaglyceroporins [J]. Environmental Health Perspectives, 2006, 114(4): 527-531. doi: 10.1289/ehp.8600

[39]

MCDERMOTT J R, JIANG X, BEENE L C, et al. Pentavalent methylated arsenicals are substrates of human AQP9 [J]. BioMetals, 2010, 23(1): 119-127. doi: 10.1007/s10534-009-9273-9

[40]

LIU Z J, SANCHEZ M A, JIANG X, et al. Mammalian glucose permease GLUT1 facilitates transport of arsenic trioxide and methylarsonous acid [J]. Biochemical and Biophysical Research Communications, 2006, 351(2): 424-430. doi: 10.1016/j.bbrc.2006.10.054

[41]

DRUWE I L, VAILLANCOURT R R. Influence of arsenate and arsenite on signal transduction pathways: An update [J]. Archives of Toxicology, 2010, 84(8): 585-596. doi: 10.1007/s00204-010-0554-4

[42]

QIAN Y, CASTRANOVA V, SHI X L. New perspectives in arsenic-induced cell signal transduction [J]. Journal of Inorganic Biochemistry, 2003, 96(2/3): 271-278.

[43]

KISHIDA K, SHIMOMURA I, KONDO H, et al. Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel [J]. The Journal of Biological Chemistry, 2001, 276(39): 36251-36260. doi: 10.1074/jbc.M106040200

[44]

KURIYAMA H, KAWAMOTO S, ISHIDA N, et al. Molecular cloning and expression of a novel human aquaporin from adipose tissue with glycerol permeability [J]. Biochemical and Biophysical Research Communications, 1997, 241(1): 53-58. doi: 10.1006/bbrc.1997.7769

[45]

ISHIBASHI K, YAMAUCHI K, KAGEYAMA Y, et al. Molecular characterization of human Aquaporin-7 gene and its chromosomal mapping [J]. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998, 1399(1): 62-66. doi: 10.1016/S0167-4781(98)00094-3

[46]

MARLAR S, JENSEN H H, LOGIN F H, et al. Aquaporin-3 in cancer [J]. International Journal of Molecular Sciences, 2017, 18(10): 2106. doi: 10.3390/ijms18102106

[47]

LI A, LU D H, ZHANG Y P, et al. Critical role of aquaporin-3 in epidermal growth factor-induced migration of colorectal carcinoma cells and its clinical significance [J]. Oncology Reports, 2013, 29(2): 535-540. doi: 10.3892/or.2012.2144

[48]

JI C, CAO C, LU S, et al. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells [J]. Cancer Chemotherapy and Pharmacology, 2008, 62(5): 857-865. doi: 10.1007/s00280-007-0674-6

[49]

LIU W J, WANG K H, GONG K M, et al. Epidermal growth factor enhances MPC-83 pancreatic cancer cell migration through the upregulation of aquaporin 3 [J]. Molecular Medicine Reports, 2012, 6(3): 607-610. doi: 10.3892/mmr.2012.966

[50]

HUANG Y T, ZHOU J, SHI S, et al. Identification of estrogen response element in aquaporin-3 gene that mediates estrogen-induced cell migration and invasion in estrogen receptor-positive breast cancer [J]. Scientific Reports, 2015, 5: 12484. doi: 10.1038/srep12484

[51]

Walz T, Fujiyoshi Y, Engel A. The AQP structure and functional implications [J]. Handbook of Experimental Pharmacology, 2009(190): 31-56.

[52]

FISCHER G, KOSINSKA-ERIKSSON U, APONTE-SANTAMARÍA C, et al. Crystal structure of a yeast aquaporin at 1.15 angstrom reveals a novel gating mechanism [J]. PLoS Biology, 2009, 7(6): e1000130. doi: 10.1371/journal.pbio.1000130

[53]

CONNER A C, BILL R M, CONNER M T. An emerging consensus on aquaporin translocation as a regulatory mechanism [J]. Molecular Membrane Biology, 2013, 30(1): 101-112. doi: 10.3109/09687688.2012.743194

[54]

YASUI H, KUBOTA M, IGUCHI K, et al. Membrane trafficking of aquaporin 3 induced by epinephrine [J]. Biochemical and Biophysical Research Communications, 2008, 373(4): 613-617. doi: 10.1016/j.bbrc.2008.06.086

[55]

GREGOIRE F, LUCIDI V, ZERRAD-SAADI A, et al. Analysis of aquaporin expression in liver with a focus on hepatocytes [J]. Histochemistry and Cell Biology, 2015, 144(4): 347-363. doi: 10.1007/s00418-015-1341-3

[56]

YOKOYAMA Y, IGUCHI K, USUI S, et al. AMP-activated protein kinase modulates the gene expression of aquaporin 9 via forkhead box a2 [J]. Archives of Biochemistry and Biophysics, 2011, 515(1/2): 80-88.

[57]

OSTHUS R C, SHIM H, KIM S, et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-myc [J]. Journal of Biological Chemistry, 2000, 275(29): 21797-21800. doi: 10.1074/jbc.C000023200

[58]

LI L, LIANG Y C, KANG L, et al. Transcriptional regulation of the Warburg effect in cancer by SIX1 [J]. Cancer Cell, 2018, 33(3): 368-385.e7. doi: 10.1016/j.ccell.2018.01.010

[59]

MAKINOSHIMA H, TAKITA M, SARUWATARI K, et al. Signaling through the phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) axis is responsible for aerobic glycolysis mediated by glucose transporter in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma [J]. The Journal of Biological Chemistry, 2015, 290(28): 17495-17504. doi: 10.1074/jbc.M115.660498

[60]

ANCEY P B, CONTAT C, MEYLAN E. Glucose transporters in cancer - from tumor cells to the tumor microenvironment [J]. The FEBS Journal, 2018, 285(16): 2926-2943. doi: 10.1111/febs.14577

[61]

WIEMAN H L, WOFFORD J A, RATHMELL J C. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking [J]. Molecular Biology of the Cell, 2007, 18(4): 1437-1446. doi: 10.1091/mbc.e06-07-0593

[62]

OLSEN J M, SATO M, DALLNER O S, et al. Glucose uptake in brown fat cells is dependent on mTOR complex 2-promoted GLUT1 translocation [J]. The Journal of Cell Biology, 2014, 207(3): 365-374. doi: 10.1083/jcb.201403080

[63]

KÖCK K, KOENEN A, GIESE B, et al. Rapid modulation of the organic anion transporting polypeptide 2B1 (OATP2B1, SLCO₂B1) function by protein kinase C-mediated internalization [J]. Journal of Biological Chemistry, 2010, 285(15): 11336-11347. doi: 10.1074/jbc.M109.056457

[64]

JUNG D, HAGENBUCH B, GRESH L, et al. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1α [J]. Journal of Biological Chemistry, 2001, 276(40): 37206-37214. doi: 10.1074/jbc.M103988200

[65]

VAVRICKA S R, JUNG D, FRIED M, et al. The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3β in hepatocellular carcinoma [J]. Journal of Hepatology, 2004, 40(2): 212-218. doi: 10.1016/j.jhep.2003.10.008

[66]

STYBLO M, del RAZO L M, VEGA L, et al. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells [J]. Archives of Toxicology, 2000, 74(6): 289-299. doi: 10.1007/s002040000134

[67]

OCHI T, KITA K, SUZUKI T, et al. Cytotoxic, genotoxic and cell-cycle disruptive effects of thio-dimethylarsinate in cultured human cells and the role of glutathione [J]. Toxicology and Applied Pharmacology, 2008, 228(1): 59-67. doi: 10.1016/j.taap.2007.11.023

[68]

APOSHIAN H V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity [J]. Annual Review of Pharmacology and Toxicology, 1997, 37: 397-419. doi: 10.1146/annurev.pharmtox.37.1.397

[69]

HUGHES M F, KENYON E M, EDWARDS B C, et al. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate [J]. Toxicology and Applied Pharmacology, 2003, 191(3): 202-210. doi: 10.1016/S0041-008X(03)00249-7

[70]

BRADHAM K D, DIAMOND G L, BURGESS M, et al. In vivo and in vitro methods for evaluating soil arsenic bioavailability: Relevant to human health risk assessment [J]. Journal of Toxicology and Environmental Health, Part B, 2018, 21(2): 83-114. doi: 10.1080/10937404.2018.1440902

[71]

KENYON E M, del RAZO L M, HUGHES M F. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate [J]. Toxicological Sciences, 2005, 85(1): 468-475. doi: 10.1093/toxsci/kfi107

[72]

LIN S, SHI Q, NIX F B, et al. A novel S-adenosyl-l-methionine: Arsenic(III) methyltransferase from rat liver cytosol [J]. Journal of Biological Chemistry, 2002, 277(13): 10795-10803. doi: 10.1074/jbc.M110246200

[73]

NARANMANDURA H, SUZUKI N, IWATA K, et al. Arsenic metabolism and thioarsenicals in hamsters and rats [J]. Chemical Research in Toxicology, 2007, 20(4): 616-624. doi: 10.1021/tx700038x

[74]

WANG T S, CHUNG C H, WANG A S S, et al. Endonuclease III, formamidopyrimidine-DNA glycosylase, and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells [J]. Chemical Research in Toxicology, 2002, 15(10): 1254-1258. doi: 10.1021/tx025535f

[75]

PARVEZ F, CHEN Y, YUNUS M, et al. Arsenic exposure and impaired lung function. Findings from a large population-based prospective cohort study [J]. American Journal of Respiratory and Critical Care Medicine, 2013, 188(7): 813-819. doi: 10.1164/rccm.201212-2282OC

[76]

AHMAD S, ANDERSON W L, KITCHIN K T. Dimethylarsinic acid effects on DNA damage and oxidative stress related biochemical parameters in B₆C₃F₁ mice [J]. Cancer Letters, 1999, 139(2): 129-135. doi: 10.1016/S0304-3835(99)00022-1

[77]

LIU J, ZHENG B, APOSHIAN H, et al. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China [J]. Journal of the Peripheral Nervous System, 2002, 7(3): 208.

[78]

SINGH R D, TIWARI R, KHAN H, et al. Arsenic exposure causes epigenetic dysregulation of IL-8 expression leading to proneoplastic changes in kidney cells [J]. Toxicology Letters, 2015, 237(1): 1-10. doi: 10.1016/j.toxlet.2015.05.014

[79]

JOMOVA K, JENISOVA Z, FESZTEROVA M, et al. Arsenic: toxicity, oxidative stress and human disease [J]. Journal of Applied Toxicology, 2011, 31(2): 95-107.

[80]

FISCHER A B, BUCHET J P, LAUWERYS R R. Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture [J]. Archives of Toxicology, 1985, 57(3): 168-172. doi: 10.1007/BF00290882

[81]

KLIGERMAN A D, DOERR C L, TENNANT A H, et al. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations [J]. Environmental and Molecular Mutagenesis, 2003, 42(3): 192-205. doi: 10.1002/em.10192

[82]

MOE B, PENG H Y, LU X F, et al. Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing [J]. Journal of Environmental Sciences, 2016, 49: 113-124. doi: 10.1016/j.jes.2016.10.004